our team
Rishi Patel – Chief Executive Officer
As Vitely’s CEO, Rishi Patel brings expertise in the intersection of the life sciences and technology sectors. His Bachelor’s degree in Biochemistry and Molecular Biology from Brown University, followed by a Master’s in Computer Science from the University of Pennsylvania laid the foundation for his diverse skillset. This combination of disciplines allows Vitely to tackle some of the most challenging problems across the field.
Before joining Vitely, Rishi honed his skills in various sectors. His tenure in big pharma involved spearheading projects that merged scientific research with practical applications, while his research experiences involved projects at the forefront of bioinformatics, decoding complex biological data with advanced computational techniques. As a consultant, he provided insights that reshaped strategies for numerous biotech enterprises, earning a reputation of resourceful problem solving and dependability.
Outside of professional endeavors, Rishi is a dedicated marathon runner and an avid piano player. The resilience and creativity emerging from these pursuits helps him drive innovation at Vitely.
Dr. Bhaumik Thakar— Head – Analytical Operations
With decades of dedicated experience in pharmaceutical research, Dr. Bhaumik Thakar has established himself as an expert in the development and validation of analytical methods for a wide range of dosage forms. His extensive knowledge and innovative approach have made him a recognized leader in several specialized areas of pharmaceutical science.
Dr. Thakar’s expertise encompasses a variety of critical domains, including BCS biowaiver, in vitro binding studies (both equilibrium and kinetic), in vitro release rate testing (IVRT), skin permeation testing (IVPT), NG&G tube studies, nitrosamine impurity analysis, extractable and leachable studies, and the characterization of complex molecules such as iron colloidal products, resin complex molecules, and NDDS complex products.
Specialties:
Praful Majhi — Head – Technical Operations
Praful Majhi’s career in the pharmaceutical industry has spanned for more than 20 years and has expertise in developing and validating analytical methods for a variety of dosage forms. He is a recognized leader in BCS biowaiver, in vitro binding (both equilibrium & kinetic binding), in vitro release rate (IVRT), skin permeation testing (IVPT), NG&G tube study, nitrosamine impurity and extractable and leachable studies.
Specialties:
Mr. Chirag Borad – Project Leader
Mr. Chirag Borad is a distinguished scientist with over 17 years of extensive experience in Analytical Research and Development (R&D). He has consistently demonstrated a proven track record in the comprehensive development, validation, and transfer of analytical methods for complex drug product formulations and drug substances.
As a recognized leader in the field, Mr. Borad brings a wealth of expertise in various specialized areas. His proficiency encompasses analytical method development and validation, nitrosamine impurity analysis, in-vitro binding studies (including both equilibrium and kinetic binding), extractable and leachable studies, Q1/Q2 reverse engineering, and stability testing for pharmaceutical products.
Yogesh Chaudhari — Head – Commercial
Yogesh Chaudhari is an accomplished and proven senior executive in life science industry with more than 18 years of experience specifically in clinical research. His expertise include development of strategies, policies and achievement of financial goals and growth.
Piyush Jogani — Head – Quality Assurance
Piyush Jogani has 12+ years of experience in clinical research industry. He is responsible for managing and directing overall quality assurance functions as per regulatory requirements. He is well-versed with regulatory guidelines like ICH M10, ICH M9, OECD, 21 CFR Part 11 etc. He has hands on experience with QA audits including study audits, internal audits, vendor audits etc.
Dr. Kailash Thakker — Strategic Advisor
Dr. Kailas Thakker’s career in the pharmaceutical industry has spanned for more than 30 years and has expertise in developing and validating analytical methods for a variety of dosage forms. She is a recognized leader in in vitro release rate and skin permeation testing and her on-going work on the advisory panel of USP has resulted in the issuance of new testing methods for topical dosage forms.